0 évaluation0% ont trouvé ce document utile (0 vote)
37 vues10 pages
Electrical stimulation at acupuncture points (acupoints) has been investigated for its utility in lowering blood glucose in hyperglycemic humans and animal models. Only two studies were found using electroacupuncture in human subjects, and in both of these, the participants were normal (nondiabetic) 14 animal studies were found, of which, 11 were performed in diabetic and normal rats.
Electrical stimulation at acupuncture points (acupoints) has been investigated for its utility in lowering blood glucose in hyperglycemic humans and animal models. Only two studies were found using electroacupuncture in human subjects, and in both of these, the participants were normal (nondiabetic) 14 animal studies were found, of which, 11 were performed in diabetic and normal rats.
Electrical stimulation at acupuncture points (acupoints) has been investigated for its utility in lowering blood glucose in hyperglycemic humans and animal models. Only two studies were found using electroacupuncture in human subjects, and in both of these, the participants were normal (nondiabetic) 14 animal studies were found, of which, 11 were performed in diabetic and normal rats.
- Electroacupuncture for Control of Blood Glucose in Diabetes: Literature Review Philip V. Peplow 1, *, G. David Baxter 2 1 Department of Anatomy, University of Otago, New Zealand 2 Centre for Physiotherapy Research, School of Physiotherapy, University of Otago, New Zealand Available online Jan 2, 2012 Received: Oct 27, 2011 Accepted: Nov 23, 2011 KEYWORDS acupoints; blood glucose; diabetes; electroacupuncture Abstract Electrical stimulation at acupuncture points (acupoints) has been investigated for its utility in lowering blood glucose in hyperglycemic humans and animal models. Only two studies were found using electroacupuncture in human subjects, and in both of these, the participants were normal (nondiabetic) and electrical stimulation was carried out at several acupoints. It had a hypoglycemic effect in obese women with caloric restric- tion diet using electrical stimulation of 2 Hz for 30 minutes/day for 20 days, but no change occurred in blood glucose of fasted patients in the other study using 1 Hz for 15 minutes. Fourteen animal studies were found, of which, 11 were performed in diabetic and normal rats. A hypoglycemic effect was observed in fasted type 1 diabetic rats using the Zusanli (ST36) leg acupoint with electrical stimulation of 15 Hz for 30 minutes and 60 minutes. In fasted type 2 diabetic rats, blood glucose was lowered using the Zusanli acupoint with electrical stimulation parameters of 15 Hz and 10 mA for 30 minutes. Also, using the Zhongwan (CV12) abdomen acupoint with electrical stimulation parameters of 15 Hz and 10 mA for 90 minutes had a hypoglycemic effect in fasted type 2 diabetic rats. In fasted normal rats, electrical stimulation of 2 Hz or 15 Hz for 30 minutes at the Zusanli or Zhongwan acupoint caused a decrease in blood glucose. Future studies are required in fasted diabetic rats to determine the effect of electroacupuncture on blood levels of insulin, lipids, fatty acids and b-endorphin, and blood ow and nerve conduction velocity. Studies with fasted normal and diabetic human subjects treated by electroacupuncture are warranted using data from animal experiments to inform such studies. 1. Introduction Diabetes mellitus is an increasingly prevalent and costly disease that can cause damage to many structures in the body. Many of theses adverse effects are caused by elevated blood levels of glucose and lipids. Diabetes without proper treatment can cause many serious long- term complications such as cardiovascular disease, chronic renal failure, and retinal damage. Type 1 diabetes is an autoimmune disease in which the immune system attacks the insulin-producing cells of the pancreas and destroys them. The pancreas then produces * Corresponding author. Department of Anatomy & Structural Biology, University of Otago, Level 2, Lindo Ferguson Building, Great King Street, Dunedin 9013, New Zealand. E-mail: phil.peplow@stonebow.otago.ac.nz Copyright 2012, International Pharmacopuncture Institute doi:10.1016/j.jams.2011.11.018 J Acupunct Meridian Stud 2012;5(1):1e10 J Acupunct Meridian Stud 2012;5(1):1e10 insufcient or no insulin. In type 2 diabetes, the pancreas is usually producing sufcient insulin but the body is not able to use the insulin effectively (so-called insulin resistance). Traditional Chinese acupuncture has long been used to control blood glucose and lipids in patients with diabetes mellitus. Apart from such treatment with needles, electrical stimulation with acupuncture is promoted as being poten- tially more effective in controlling diabetes. Electro- acupuncture applied at different frequencies may cause the release of endogenous opioid peptides such as b-endorphin from the adrenal gland, and thereby enhance insulin secre- tion [1,2]. The aim of this paper was to review experimental studies of electroacupuncture for controlling blood glucose in diabetes, to identify the acupoints and electrical stim- ulation parameters used and those found to be effective, and establish where further studies are warranted. 2. Materials and methods 2.1. Literature review Original research papers investigating the effects of elec- troacupuncture in humans and animal models with type 1 and type 2 diabetes, and published up to December 2010 were retrieved and used for this review. Relevant papers were sought and obtained from library sources and the online database PubMed using EndNote X1 (Thomson Reu- ters, Carlsbad, CA, USA). Search terms were acupuncture, control of diabetes, blood sugar, and blood glucose. Additional secondary sources of information included reference lists from retrieved papers, and pertinent papers identied by hand searches of relevant journals not found from the database. EndNote searches were carried out by one of the authors at the beginning of January 2011, and articles for inclusion and exclusion were identied and conrmed. 2.2. Inclusion/exclusion criteria We included studies that met the following criteria: (1) studies were performed in humans or rats, mice, rabbits or some other suitable small laboratory animal model with type 1 or type 2 diabetes, or were normal; (2) electro- acupuncture was investigated as the primary intervention (independent variable); (3) the sites of acupuncture nee- dles were dened or implied; (4) the parameters for electrical stimulation in electroacupuncture were dened; (5) at least one outcome or index of electroacupuncture treatment relating to control of diabetes was identied as the dependent variable; and (6) the treatment outcome or index identied was blood glucose, blood lipid, blood insulin, b-endorphin, blood ow, pain score, or nerve conduction velocity. Studies excluded from this study were: (1) in vitro studies involving cells; (2) studies reported in languages for which no English language translation was available; (3) reviews and meta-analyses; (4) studies that did not use electroacupuncture; and (5) studies for which only an abstract was available. 2.3. Retrieved articles The process followed for retrieving articles from the liter- ature search is summarized in Fig. 1. 2.4. Items for data extraction For included articles, the following data were extracted and tabulated: research method, sample type, acupoints, electroacupuncture parameters, treatment outcomes. Figure 1 Flowchart of literature search: studies of electroacupuncture for control of blood glucose. 2 P.V. Peplow, G.D. Baxter 3. Results Two human studies and 14 animal studies (11 in rats, 2 of which included mice; and 1 each in mice, rabbits and sand rats) were identied [1e16], and are summarized in Tables 1 and 2. However, due to the small number of human studies, the main focus has been on studies in rats. The acupoints and electrical stimulation parameters used in the studies with diabetic and normal (nondiabetic) rats are given in Tables 3 and 4. 4. Discussion Treatment strategies targeting blood glucose, blood pres- sure, triglyceride and low-density lipoprotein cholesterol levels, together with lifestyle modications, are central to the management of diabetes [17e19]. These strategies reduce the risk of cardiovascular complications, and also reduce the risk or slow the progression of microvascular complications such as retinopathy and nephropathy [19]. Therapies currently in use involve pharmacological agents, lifestyle modications including exercise, weight loss, reduced caloric and intake of dietary fat, cessation of smoking, and acupuncture. Other treatment procedures for diabetes include laser light in association with electro- magnetic elds, and electrostimulation [20]. The retrieved articles from the literature search showed that most of the published studies using electroacupuncture were performed in rats, with only two studies reported in humans, who were normal (nondiabetic) volunteers. Consequently, the main focus of this review was the data from the rat studies because these could inform future studies in humans. Of the two studies in human patients with hyperglycemia treated by electroacupuncture, one involved obese women receiving electrical stimulation at 2 Hz for 30minutes/day for 20 days at ear, body and leg acupoints, including Zusanli, whereas in the other study, patients received electrical stimulation at 1 Hz and 15 minutes at a combination of acupoints. The frequency of electrical stimulation in both studies was very low. In the rst study with obese women, a decrease in blood glucose and an increase in blood insulin occurred using electroacupuncture together with a caloric restriction diet. However, it is not known to what extent the restriction diet contributed to these changes. There was no effect on blood glucose in the second study, although blood insulin decreased shortly after the end of acupunc- ture and then increased after the next 30 minutes. Only in the second study were the subjects reported to have been fasted during the experimental period. Blood glucose in type 1 diabetic rats was mostly unchanged following electroacupuncture treatment. For the three studies in which the rats were fasted and which therefore provided the most meaningful information on treatment outcomes, a hypoglycemic effect and increased insulin sensitivity were observed only in the study using the Zusanli (ST36) leg acupoint, with electrical stimulation at 15 Hz for 30 minutes and 60 minutes. One of the other two studies used Zusanli and Sanyinjiao (SP6) acupoints on the right leg and electrical stimulation parameters of 4 Hz or 20 Hz and 50 mA/day for 30 minutes for 4 weeks. This electrical current was most likely too low because other studies used currents of 10 mA. In the other study, while using the Zusanli acupoint, the frequency of electrical stimulation was 2 Hz for 30 minutes, and this was most likely too low for these animals because other studies used 15 Hz or 20 Hz. None of the three studies reported blood insulin or b-endorphin in the diabetic rats following elec- troacupuncture treatment. By contrast, in both studies with fasted type 2 diabetic rats, there was a decrease in blood glucose and an increase in blood insulin. One study used the Zusanli acupoint with electrical stimulation parameters of 15 Hz and 10 mA for 30 minutes, whereas the other study used the Zhongwan (CV12) abdomen acupoint with electrical stimulation parameters of 15 Hz and 10 mA for 90 minutes. There were no reported measurements of blood b-endorphin in fasted type 2 diabetic rats. In Tradi- tional Chinese Medicine, the Zusanli (ST36) acupoint is considered as a primer to control blood glucose [21], whereas the Sanyinjiao (SP6) acupoint not only regulates blood glucose, but also gynecological conditions [22]. The Zhongwan acupoint regulates the stomach [23]. In all four studies of fasted normal rats using the Zusanli acupoint and electrical stimulation parameters of 15 Hz and 10 mA for 30 minutes; 15 Hz for 30 minutes and 60 minutes; 2 Hz for 30 minutes, then after 90 minutes, 2 Hz or 100 Hz for 30 minutes; or 2 Hz for 30 minutes; blood glucose was decreased. Also, blood glucose was decreased in both studies using the Zhongwan acupoint with electrical stim- ulation parameters of 15 Hz for 30 minutes and 2 Hz for 30 minutes. In two of the three studies in which blood insulin was determined, it was found to be increased. Also, blood b-endorphin was increased in both of the studies in which it had been measured. Normal rats would appear to be more sensitive to the hypoglycemic action of electrical stimula- tion at the Zusanli acupoint with 2 Hz for 30 minutes than type 1 diabetic rats were. The paucity of data on treatment outcomes such as blood insulin, blood lipids and fatty acids, blood b-endorphin, blood ow and nerve conduction velocity did not enable a rational conclusion to be reached of the effect of elec- troacupuncture on these outcomes in fasted diabetic and normal rats. Further studies are warranted to provide this information and also studies should be undertaken in fasted normal and diabetic human subjects, using as a guide those electroacupuncture parameters resulting in a hypoglycemic action in the rat studies reviewed here. It has been reported that approximately 30% of human patients will experience hyperglycemia during hospitaliza- tion, and many do not have diabetes or are undiagnosed. Blood sugar levels tend to be increased when a patient is critically ill, for example, after heart surgery e a condition referred to as stress hyperglycemia [24,25]. Stress hyper- glycemia in seriously ill patients worsens outcomes with higher medical costs, higher incidence of infection and readmission to the hospital, and higher mortality rates. A recent study found that 40% of elderly patients admitted to hospital had hyperglycemia; excluding those patients already diagnosed with diabetes, 25% of the patients were hyperglycemic [26]. It therefore seems likely that electrical stimulation at selected acupoints could have an important clinical application in reducing hyperglycemia in patients during hospitalization. Electroacupuncture for control of blood glucose in diabetes 3 Table 1 Searched studies using electroacupuncture in humans. Authors, reference EA treatment Subjects Measured outcomes of electroacupuncture treatment Normal Diabetic Blood glucose Blood insulin Blood lipids Blood b-endorphin Blood ow Nerve conduction velocity Cabioglu, Ergene 2006 Am J Chin Med 34:367e76 [3] 52 healthy women allocated to 3 groups: placebo EA group (n Z15), EA group (n Z20), diet restriction group (n Z20) 2 Hz, 30 min/d, 20 d, Ear points Hunger and Shen Men and body points LI4, LI11, ST36, ST44 Obese women; a 1450 kcal diet for women in EA group, placebo EA group, and diet restriction group for 20 d Blood glucose decreased Serum insulin increased Szczudlik, Lypka 1984 Acupunct Electrother Res, 9:1e9 [4] 10 patients, 1 Hz, 15 min needle insertion to Du20, Extra 1, Extra 2 - symmetrical, GB20- symmetrical, LI4 - symmetrical and twirled to obtain degi (Tei Chi) effect; current increased gradually to obtain painless tingling sensation in stimulated area, avoiding muscle contraction Adult Serum glucose not changed from normal values in investigated subjects who were fasted during experimental period Serum insulin decreased at 5 min after end of acupuncture, and increased after next 30 min EA Zelectroacupuncture. 4 P . V . P e p l o w , G . D . B a x t e r Table 2 Searched studies using electroacupuncture in animals. Authors, reference Species, EA treatment Experimental animals Measured outcomes of electroacupuncture treatment Normal Diabetic Blood glucose Blood insulin Blood lipids Blood b- endorphin Blood ow Nerve conduction velocity Liang et al. 2011 Evidence-Based Comp Altern Med doi. 10.1155/2011/ 735297 [5] Mice, males, 16 db/db divided into two groups of 8, 14 db/m divided into 2 groups. 3 Hz/0.5e0.8 mA 10 min/d, 5 treatments/wk, 8 wk acupuncture needles inserted at Zusanli (ST36) and Guanyuan (CV4) points; needles at these two points were linked to Zusanli on other side on following day Non-diabetic heterozygote litter mates Genetic obese diabetic Blood glucose decreased in diabetic mice Insulin levels maintained and increased insulin sensitivity in diabetic mice Free fatty acid levels decreased in blood of diabetic mice with no signicant effect on triglyceride or total cholesterol; no effect on free fatty acid, triglyceride or total cholesterol levels in blood of non-diabetic mice Pai et al. 2009 J Acupunct Meridian Stud 2: 147e151 [6] Rats, 36 males randomly divided into groups of 9. 15 Hz/10 mA/ 30 min Two acupuncture needles inserted into anterior tibial muscles at both Zusanli (ST36) points Adults fasted for 12 h STZ-neonatal type 2 fasted for 12 h Blood glucose decreased in normal and type 2 diabetic rats Insulin secretion increased in normal and type 2 diabetic rats Ishizaki et al. 2009 Metab Clin Exp 58: 1372e1378 [7] Rats, 27 males divided into EA group (n Z13) and control group (n Z14). 15 Hz/10 mA/90 min Acupuncture needles inserted into muscle layer at 2 points between top of xiphoid process and upper border of pubic symphysis Genetic type 2 fasted for 12e20 h Fasting blood glucose decreased Plasma insulin increased during fasting period Higashimura et al. 2009 Autonomic Neurosci Basic Clin 150: 100e103 [8] Rats, 25 males; 2 wk after STZ, randomly divided into groups. 20 Hz/10 mA/10 min. Two acupuncture needles inserted into right tibialis anterior muscle STZ-adult type 1 not reported as being fasted (n Z7) No change in plasma glucose; response of plasma glucose to insulin increased Chang et al. 2006 Life Sci 79: 967e971 [9] Rats, males normal and STZ diabetic rats divided randomly into experimental and control groups of 8. 15 Hz, 30 and 60 min. Acupuncture needles inserted into anterior tibia muscles at both Zusanli (ST36) points Adult STZ-adult type 1 fasted for 12 h Blood glucose decreased in normal and type 1 diabetic rats; response of plasma glucose to insulin increased in insulin challenge test in normal and type 1 diabetic rats No change in normal rats and no increase in normal rats undergoing iv GTT Tseng et al. 2005 Am J Chin Med 33: 767e778 [10] Rats, 7 animals 2 Hz, 30 min, then after 90 min, 2 Hz 30 min (n Z2), 100 Hz 30 min (n Z2). Acupuncture needle inserted 5 mm deep at bilateral Zusanli (ST36) acupoints; 2 Hz (n Z3) at nonacupoints Adults fasted for 12 h After 2 Hz, EA blood glucose decreased but 60 min after end of EA, blood glucose was raised; blood glucose not changed after a second 2 Hz or 100 Hz stimulus after 90 min (continued on next page) E l e c t r o a c u p u n c t u r e f o r c o n t r o l o f b l o o d g l u c o s e i n d i a b e t e s 5 Table 2 (continued) Authors, reference Species, EA treatment Experimental animals Measured outcomes of electroacupuncture treatment Normal Diabetic Blood glucose Blood insulin Blood lipids Blood b- endorphin Blood ow Nerve conduction velocity Lin et al. 2005 Conf Proc IEEE, Eng Med Biol Soc 4: 4271e4274 [11] Rats, males divided randomly into groups, including normal (n Z12) and EA groups (n Z11). 4 or 20 Hz, 30 min/50 mA/day, 4 weeks acupoints ST36, SP9 (positive charge), SP6, K3 (negative charge) in right lower limb Adults STZ-adult type 1 diabetes No change in blood glucose for normal and diabetic rats following electrical stimulation of acupoints No change in blood ow in footpad for diabetic rats following electrical stimulation of acupoints compared to normal rats For diabetic rats, at 3rd and 4th weekend of electrical stimulation, NCV was increased Chang et al. 2005 Neurosci Lett 379: 69e73 [12] Rats, male, 2 Hz, 30 min, Mice, 2 Hz, 30 min. Acupuncture needles inserted into anterior tibia muscles at both Zusanli (ST36) points Adults, Adults STZ-adult type 1 diabetes Plasma glucose decreased in non-fasting (n Z8) and fasting normal rats (n Z7) but not in fasting type 1 diabetic rats (n Z7); a small decrease in plasma glucose occurred with EA at nonacupoint in normal rats (n Z8); plasma glucose decreased in non-fasting (n Z8) and fasting normal mice (n Z7) Plasma insulin increased in fasting normal rats Plasma b- endorphin increased in fasting normal rats Lin et al. 2004 Neurosci Lett 366: 39e42 [13] Rats, male randomly divided into ADX and sham groups (n Z6). Mice, male. 15 Hz, 30 min, Acupuncture needles inserted into muscle layer at depth of 2 mm at Zhongwan and Gwanyuan acupoints on abdomen Sham and ADX adult Plasma glucose decreased in sham rats (n Z6) and mice (n Z9); adrenalectomy partially reduced plasma glucose response to EA in rats (n Z6) and mice (n Z8) Plasma insulin not changed in ADX rats Plasma b- endorphin not changed in ADX rats Zeng, Li 2002 J Trad Chin Med 22: 134e136 [14] Rabbits, 14 males, 10 females. 25 min. Acupuncture needle inserted into Weiwanxiashu and/or Zusanli acupoint Alloxan-adult type 1 diabetes Plasma glucose and glucagon decreased following acupuncture at Weiwanxiashu point (n Z8) but not when acupuncture given at Zusanli point alone (n Z8); decrease in plasma glucose and glucagon more pronounced when acupuncture given at both Weiwanxiashu and Zusanli (n Z8) 6 P . V . P e p l o w , G . D . B a x t e r Lin et al. 2002 Neurosci Lett 326: 17e20 [2] Rats, male divided into ADX (n Z9) and sham group (n Z8) Mice, male ADX (n Z8) and sham (n Z7) 2 Hz 30 min. Acupuncture needles inserted into muscle layer at Zhongwan and Gwanyuan acupoints sham and ADX adult fasted Plasma glucose decreased in sham rats and mice; no effect in ADX rats and mice Plasma insulin increased in sham rats; no effect in ADX rats Plasma b- endorphin increased in sham rats; no effect in ADX rats Shapira et al. 2000 Diabetol 43: 809e813 [15] Sand rats, 29 diabetic male randomly assigned to 3 groups: abdominal EA, back EA, and control. 15 Hz, 80 mA, 30 min. Acupuncture needles inserted 2 mm into muscle layer at Zhongwan and Gwanyuan acupoints Type 2 diabetes Decrease in blood glucose between real (abdominal EA) and placebo groups (back EA) throughout the 3 wk Serum insulin was not changed between real and placebo groups Plasma triglycerides and cholesterol were not changed between real and placebo groups Chang et al. 1999 Diabetol 42: 250e255 [1] Rats, male divided into experimental groups and control group (EA at non-acupoint). 15 Hz, 10 mA, 30 min. Acupuncture needles inserted into muscle layer at Zhongwan (positive charge) and Gwanyuan acupoints (negative charge) Adults Adult genetic type 1 diabetes (BB/W), STZ-adult type 1 diabetes and STZ- neonatal type 2 diabetes Plasma glucose decreased in normal rats (n Z8) and type 2 diabetic rats (n Z8); no effect in type 1 diabetic rats (BB/W, n Z8; STZ- induced, n Z7) Plasma insulin increased in normal rats and type 2 diabetic rats Plasma b- endorphin increased in normal rats and type 2 diabetic rats; also increased in STZ type 1 diabetic rats Ikeda et al. 1991 Acupunct Electro- Ther Res 16: 127e134 [16] Rats, 56 male. 50 Hz, 5 V 10 min. Two acupuncture needles were inserted to deep muscle layer at Chuin acupoint; other acupoints in abdomen also chosen and to front paw and to leg and thigh Adults Blood glucose levels increased following EA of middle upper abdominal area; stimulation of other areas of abdomen or front paw, leg or thigh did not alter blood sugar level ADX Zadrenalectomized; EA Zelectroacupuncture; GTT Zglucose tolerance test; NCV Znerve conduction velocity; STZ Zstreptozotocin E l e c t r o a c u p u n c t u r e f o r c o n t r o l o f b l o o d g l u c o s e i n d i a b e t e s 7 Table 3 Acupoints used in studies of diabetic rats treated by electroacupuncture. Type 1 diabetes Authors, reference Experimental animals EA parameters Acupoints Measured outcomes of treatment Blood glucose Blood insulin Blood b-endorphin Higashimura et al. 2009 Autonomic Neurosci Basic Clin 150: 100e103 [8] STZ-adult, type 1 diabetes, not reported as being fasted 20 Hz, 10 mA, 10 min, leg acupoints Needles inserted into right tibialis anterior muscle No change; response of plasma glucose to insulin increased Chang et al. 2006 Life Sci 79: 967e971 [9] STZ-adult, type 1 diabetes, fasted for 12 h 15 Hz, 30 and 60 min, leg acupoints ST36 Decreased; response of plasma glucose to insulin increased in insulin challenge test Lin et al. 2005 Conf Proc IEEE, Eng Med Biol Soc 4: 4271e4274 [11] STZ-adult type 1 diabetes, fasted 4 or 20 Hz, 50 mA/day, 30 min 4 wk, right leg acupoints ST36, SP9 No change Chang et al. 2005 Neurosci Lett 379: 69e73 [12] STZ-adult type 1 diabetes, fasted 2 Hz, 30 min, leg acupoints ST36 No change Chang et al. 1999 Diabetol 42: 250e255 [1] Adult genetic type 1 diabetes, not reported as being fasted 15 Hz, 10 mA, 30 min, body acupoint (abdomen) Zhongwan (CV12) No change Chang et al. 1999 Diabetol 42: 250e255 [1] STZ-adult type 1 diabetes, not reported as being fasted 15 Hz, 10 mA, 30 min, body acupoint (abdomen) Zhongwan (CV12) No change Type 2 diabetes Pai et al. 2009 J Acupunct Meridian Stud 2: 147e151 [6] STZ-neonatal type 2 diabetes, fasted for 12 h 15 Hz, 10 mA, 30 min, leg acupoints ST36 Decreased Increased Ishizaki et al. 2009 Metab Clin Exp 58: 1372e1378 [7] Adult genetic type 2 diabetes, fasted for 12e20 h 15 Hz, 10 mA, 90 min, body acupoint (abdomen) Zhongwan (CV12) Decreased Increased Chang et al. 1999 Diabetol 42: 250e255 [1] STZ-neonatal type 2 diabetes, not reported as being fasted 15 Hz, 10 mA, 30 min, body acupoint (abdomen) Zhongwan (CV12) Decreased Increased EA Zelectroacupuncture; STZ Zstreptozotocin. 8 P . V . P e p l o w , G . D . B a x t e r Table 4 Acupoints used in studies of normal rats treated by electroacupuncture. Normal (nondiabetic) Authors, reference Experimental animals EA parameters Acupoints Measured outcomes of treatment Blood glucose Blood insulin Blood b-endorphin Pai et al. 2009 J Acupunct Meridian Stud 2: 147e151 [6] Adult normal, fasted for 12 h 15 Hz, 10 mA, 30 min, leg acupoints ST36 Decreased Increased Chang et al. 2006 Life Sci 79: 967e971 [9] Adult normal, fasted for 12 h 15 Hz, 30 and 60 min, leg acupoints ST36 Decreased; plasma glucose decreased from 15 to 90 min in animals undergoing iv GTT No change; no increase in animals undergoing iv GTT Tseng et al. 2005 Am J Chin Med 33: 767e778 [10] Adult normal, fasted for 12 h 2 Hz 30 min, then after 90 min, 2Hz, 30 min (n Z2), 100 Hz, 30 min (n Z2), leg acupoints ST36 Decreased Lin et al. 2005 Conf Proc IEEE, Eng Med Biol Soc 4: 4271 e4274 [11] Adult normal, not reported as being fasted 4 or 20 Hz 50 mA/day, 30 min, 4 wk, right leg acupoints ST36, SP9 No change Chang et al. 2005 Neurosci Lett 379: 69e73 [12] Adult normal, non- fasted and fasted 2 Hz Hz, 30 min, leg acupoints ST36 Decreased in non- fasting and fasting state Increased in fasting state Lin et al. 2004 Neurosci Lett 366: 39e42 [13] Adult normal, (sham) fasted 12 h 15 Hz, 30 min, body acupoint (abdomen) Zhongwan (CV12) Decreased Lin et al. 2002 Neurosci Lett 326: 17e20 [2] Adult normal, (sham) fasted 2 Hz, 30 min, body acupoint (abdomen) Zhongwan (CV12) Decreased Increased Increased Ikeda et al. 1991 Acupunct Electro-Ther Res 16: 127e134 [16] Adult normal, not reported as being fasted 50 Hz, 5 V, 10 min, body acupoint (abdomen) Chuin Right sides of middle abdomen, 6 other abdominal acupoints Increased, Increased, No change GTT Zglucose tolerance test. E l e c t r o a c u p u n c t u r e f o r c o n t r o l o f b l o o d g l u c o s e i n d i a b e t e s 9 References 1. Chang SL, Lin JG, Chi TC, Liu IM, Cheng JT. An insulin- dependent hypoglycaemia induced by electroacupuncture at the Zhongwan (CV12) acupoint in diabetic rats. Diabetologia. 1999;42:250e255. 2. Lin JG, Chang SL, Cheng JT. Release of beta-endorphin from adrenal gland to lower plasma glucose by the electroacupuncture at Zhongwan acupoint in rats. Neurosci Lett. 2002;326:17e20. 3. Cabioglu MT, Ergene N. Changes in levels of serum insulin, C-peptide and glucose after electroacupuncture and diet therapy in obese women. Am J Chin Med. 2006;34:367e376. 4. Szczudlik A, Lypka A. Acupuncture-induced changes in human plasma insulin level. Acupunct Electrother Res. 1984;9:1e9. 5. Liang F, Chen RT, Nakagawa A, Nishizawa M, Tsuda S, Wang H, et al. Low-frequency electroacupuncture improves insulin sensitivity in obese diabetic mice through activation of SIRT1/PGC-1a in skeletal muscle. Evidence-Based Complement Altern Med; 2011. doi:10.1155/2011/735297. 6. Pai HC, Tzeng CY, Lee YC, Chang CH, Lin JG, Cheng JT, et al. Increase in plasma glucose lowering action of rosiglitazone by electroacupuncture at bilateral Zusanli acupoints (ST.36) in rats. J Acupunct Meridian Stud. 2009;2:147e151. 7. Ishizaki N, Okushi N, Yano T, Yamamura Y. Improvement in glucose tolerance as a result of enhanced insulin sensitivity during electroacupuncture in spontaneously diabetic GotoeKakizaki rats. Metab Clin Exp. 2009;58:1372e1378. 8. Higashimura Y, Shimoju R, Maruyama H, Kurosawa M. Electro- acupuncture improves responsiveness to insulin via excitation of somatic afferent bers in diabetic rats. Autonomic Neurosci Basic Clin. 2009;150:100e103. 9. Chang SL, Lin KJ, Lin RT, Hung PH, Lin JG, Cheng JT. Enhanced insulin sensitivity using electroacupuncture on bilateral Zusanli acupoints (ST 36) in rats. Life Sci. 2006;79:967e971. 10. Tseng CS, Shen WC, Cheng FC, Chen GW, Li TC, Hsieh CL. Dynamic change in energy metabolism by electroacupuncture stimulation in rats. Am J Chin Med. 2005;3:767e778. 11. Lin CC, Chen MC, Yu SN, Ju MS. Chronic electrical stimulation of four acupuncture points on rat diabetic neuropathy. Conf Proc IEEE, Eng Med Biol Soc. 2005;4:4271e4274. 12. Chang SL, Tsai CC, Lin JG, Hsieh CL, Lin RT, Cheng JT. Involvement of serotonin in the hypoglycemic response to 2 Hz electroacupuncture of zusanli acupoint (ST36) in rats. Neurosci Lett. 2005;379:69e73. 13. Lin JG, Chen WC, Hsieh CL, Tsai CC, Cheng YW, Cheng JT, et al. Multiple sources of endogenous opioid peptide involved in the hypoglycemic response to 15 Hz electroacupuncture at the Zhongwan acupoint in rats. Neurosci Lett. 2004;366:39e42. 14. Zeng Z, Li Y. Effects of acupuncture at Weiwanxiashu and Zusanli points on blood glucose and plasma pancreatic glucagon contents in diabetic rabbits. J Trad Chin Med. 2002; 22:134e136. 15. Shapira MY, Appelbaum EY, Hirshberg B, Mizrahi Y, Bar-On H, Ziv E. A sustained, non-insulin related, hypoglycaemic effect of electroacupuncture in diabetic Psammomys obesus. Dia- betologia. 2000;43:809e813. 16. Ikeda H, Kawatani M, Takeshige C. Electrical stimulation in restricted area of abdominal skin increased glucose level via the pancreatic branch of the vagal nerve in the rat. Acupunct Electrother Res. 1991;16:127e134. 17. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007;298:309e316. 18. Nordestgaard BG, Benn M, Schnohr P, Tybjrg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298:299e308. 19. American Diabetic Association. Standards of medical care in diabetes e 2008. Diabetes Care. 2008;31(suppl. 1):S12eS54. 20. Longo L. The role of laser in diabetes management. In: Waynant R, Tata DB, editors. Proceedings of Light-Activated Tissue Regeneration and Therapy Conference. London: Springer; 2008. p. 215e220 (Lecture Notes in Electrical Engi- neering, 12). 21. Lin RT, Tzeng CY, Lee YC, Ho WJ, Cheng JT, Lin JG, et al. Acute effect of electroacupuncture at the Zusanli acupoints on decreasing insulin resistance as shown by lowering plasma free fatty acid levels in steroid-background male rats. BMC Comple- ment Altern Med. 2009;9:26. doi:10.1186/1472-6882-9-26. 22. Wong CL, Lai KY, Tse HM. Effects of SP6 acupressure on pain and menstrual distress in young women with dysmenorrhea. Complement Ther Clin Pract. 2010;16:64e69. 23. Delaney C, Leonard DB, Kitsch L. The Acupuncture Point Book. Available from: http://www.medicineatyourfeet.com/% 20Master%20Copy%20RD%20Book [accessed 13.04.11]. 24. Levetan C. Controlling hyperglycemia in the hospital: a matter of life and death. Clin Diabetes. 2000;18:17e23. 25. Dungan KM, Braithwaite SS, Preiser J-C. Stress hyperglycaemia. Lancet. 2009;373:1798e1807. 26. Iglesias P, Polini A, Munoz A, Dardano A, Prado F, Castiglioni M, et al. Fasting hyperglycaemia and in-hospital mortality in elderly population. Int J Clin Pract. 2011;65:308e313. 10 P.V. Peplow, G.D. Baxter
Tumor Necrosis Factor (TNF-α) and C-reactive Protein (CRP) are Positively Associated with the Risk of Chronic Kidney Disease in Patients with Type 2 Diabetes